PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

The Primary Logistics Needs of Life Science Companies

The low volume life science market has significant complexities when it comes to logistics. Shippers must have an educated understanding of Good Distribution Practice (GDP) methods and processes, and detailed knowledge of how to ship the pharma related product in question. These products can range from novel prototypes up to final stage development pre-trial products, including component ingredients and failed items being returned for analysis.

As a consequence of the complexity, the need for add-on features when shipping are high on a per shipment basis. Unique packaging, individual insurance and special requests in-transit are often what is required for a temperature-sensitive, high-value shipment to be delivered in its desired state and on time. Additionally, customs teams in each country do not regularly see items like these, so it’s easy to see why most life science companies have major concerns when shipping. It’s therefore essential to work with a specialist logistics partner to effectively outsource the process beyond standard logistics provisions.

YSDS Life Science sat down with four prominent UK life science companies, all identifying four different but equally important aspects of the logistical needs of the life sciences industry.

A Close Collaboration Between The Shipper and Logistics Provider

Products shipped in the Life Science industry are often referred to as “high value”. This is generally speaking a misnomer however, as the products themselves have little monetary value. The value lies in the role they play in the bigger picture; these are business-critical shipments for companies often in the start-up, spin-out or SME phase. The success of a project and conformity to agreed timelines can have significant impacts on proof-of-concept, funding conversations, and meeting critical strategic markers with mentors. So, what’s the most important factor for shipping success in this low volume-high value market?

LocateBio specialises in developing next generation orthobiologic products to relieve symptoms for people with musculoskeletal conditions. Its products are novel, with complex shipping requirements. “As a startup company, we require a fast turnaround from collection to delivery to ensure that project timelines are adhered to and lastminute requests are processed quickly and efficiently,” says Lyndsey Johnson – Scientific Programme Manager at LocateBio.

What Johnson highlights as the most important factor when working with a logistics provider is regular communication with a dedicated contact who can handle their account throughout the entire shipping process: “This saves us having to bring new people up to speed each time a shipment is raised, and makes the process so much easier”.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026